Call for Nominations: Else Kröner Fresenius Prize for Medical Research 2023 – Topic: Diseases of worldwide significance
Bad Homburg v.d. Höhe, Germany, May 30, 2022 – In 2023, the foundation Else Kröner-Fresenius-Stiftung (EKFS) will award its international research prize for outstanding scientific contributions in biomedical sciences. The field chosen for 2023 is Diseases of worldwide significance. The call for nominations is open until September 13, 2022.
The Else Kröner Fresenius Prize for Medical Research amounts to EUR 2.5 million, of which EUR 500,000 shall be awarded personally to the recipient and EUR 2.0 million dedicated to the award-winners future research. The prize was presented for the first time in 2013 on the occasion of the 25th anniversary of Else Kröner’s death. Since then, it has been awarded to three researchers in changing fields of biomedical research.
Candidates for the prize in 2023 must be researchers in basic medical sciences or clinical sciences who have made outstanding scientific contributions with regard to diseases that pose a major burden in low, middle, and high income countries. In addition, the candidate’s work in the coming years is expected to yield further groundbreaking discoveries or advances with respect to diagnosis or treatment that should be applicable globally.
Information on the timing and on nomination conditions can be found at: www.ekfprize23.de
Else Kröner-Fresenius-Stiftung (EKFS) – Advancing research. Helping people.
Else Kröner-Fresenius-Stiftung is a non-profit foundation dedicated to the funding and advancement of medical research and the support of humanitarian projects. To date the foundation has funded around 2,300 projects. With an annual funding volume currently amounting to over 60 million euros it is the largest foundation in Germany that actively funds and supports medicine. You can find more information at: www.ekfs.de/en
Tel.: + 49 6172 8975-24
(Deutsch) Wissenschaftlicher Ansprechpartner:
Dr. Alexander Lehmann
+49 (6172) 8975-25
(Deutsch) Weitere Informationen: